European Companies Search Engine
No longer Managing Director: Stefan Strobl · No longer Authorized signatory (ppa): Jan Kürschner · Managing Director (3) · Shareholder agreement · Name: BioNTech Europe GmbH · Corporate Purpose Hrb 7 Aug 2020 German Trade Register Announcements, Germany
Overview
Text
HRB 46774: BioNTech Small Molecules GmbH, Mainz, c/o BioNTech AG,
An der Goldgrube 12, 55131 Mainz
. The shareholders' meeting of 8 July 2020 decided to amend the partnership agreement in Sections 1 (company and registered office of the company) and section 2 (object of the company). The company and the object of the company have been changed. New company: BioNTech Europe GmbH. New business object: The development, manufacture and distribution of pharmaceuticals and medical devices (not retail), as well as materials intended for use in pharmacology and toxicology. No longer Managing Director: Dr. Strobl, Stefan, Gauting, *??.??.????. Managing Director: Dr. Böhler, Michael Karl, Berlin, *??.??.????; Kürschner, Jan, Munich, *??.??.????. After the change of the power of representation, Managing Directors continue to be Managing Directors: Dr. ????????, ?????, Munich, *??.??.????, with the power to enter into legal transactions on behalf of the company a.s. a representative of a third party. Procura terminated: Kürschner, Jan, Munich, *??.??.????.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: BioNTech Europe GmbH, Mainz, Germany.